Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Cash on Hand 2010-2024 | BMY

Bristol Myers Squibb cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Bristol Myers Squibb cash on hand for the quarter ending September 30, 2024 was $8.094B, a 5.32% increase year-over-year.
  • Bristol Myers Squibb cash on hand for 2023 was $12.28B, a 32.71% increase from 2022.
  • Bristol Myers Squibb cash on hand for 2022 was $9.253B, a 45.46% decline from 2021.
  • Bristol Myers Squibb cash on hand for 2021 was $16.966B, a 7.17% increase from 2020.
  
Bristol Myers Squibb Annual Cash on Hand
(Millions of US $)
2023 $12,280
2022 $9,253
2021 $16,966
2020 $15,831
2019 $15,393
2018 $8,759
2017 $6,812
2016 $6,350
2015 $4,270
2014 $7,435
2013 $4,525
2012 $2,829
2011 $8,733
2010 $7,301
2009 $8,514
Bristol Myers Squibb Quarterly Cash on Hand
(Millions of US $)
2024-09-30 $8,094
2024-06-30 $6,653
2024-03-31 $9,670
2023-12-31 $12,280
2023-09-30 $7,685
2023-06-30 $8,730
2023-03-31 $9,269
2022-12-31 $9,253
2022-09-30 $9,027
2022-06-30 $13,228
2022-03-31 $14,968
2021-12-31 $16,966
2021-09-30 $15,663
2021-06-30 $12,970
2021-03-31 $12,930
2020-12-31 $15,831
2020-09-30 $21,155
2020-06-30 $21,658
2020-03-31 $18,322
2019-12-31 $15,393
2019-09-30 $32,542
2019-06-30 $29,357
2019-03-31 $8,764
2018-12-31 $8,759
2018-09-30 $6,830
2018-06-30 $6,075
2018-03-31 $6,770
2017-12-31 $6,812
2017-09-30 $7,122
2017-06-30 $6,505
2017-03-31 $6,109
2016-12-31 $6,350
2016-09-30 $5,560
2016-06-30 $4,651
2016-03-31 $4,307
2015-12-31 $4,270
2015-09-30 $5,413
2015-06-30 $5,476
2015-03-31 $7,607
2014-12-31 $7,435
2014-09-30 $7,221
2014-06-30 $7,175
2014-03-31 $7,059
2013-12-31 $4,525
2013-09-30 $2,722
2013-06-30 $2,799
2013-03-31 $2,533
2012-12-31 $2,829
2012-09-30 $2,930
2012-06-30 $5,037
2012-03-31 $5,029
2011-12-31 $8,733
2011-09-30 $8,193
2011-06-30 $7,670
2011-03-31 $6,793
2010-12-31 $7,301
2010-09-30 $8,359
2010-06-30 $7,454
2010-03-31 $6,776
2009-12-31 $8,514
2009-09-30 $6,669
2009-06-30 $8,120
2009-03-31 $8,920
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $114.186B $45.006B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.398B 13.59
Gilead Sciences (GILD) United States $113.522B 20.56
Vertex Pharmaceuticals (VRTX) United States $102.146B 0.00
CSL (CSLLY) Australia $83.739B 0.00
Regeneron Pharmaceuticals (REGN) United States $77.829B 17.72
GSK (GSK) United Kingdom $69.285B 8.02
Argenex SE (ARGX) Netherlands $37.792B 0.00
Alnylam Pharmaceuticals (ALNY) United States $30.810B 0.00
BioNTech SE (BNTX) Germany $26.468B 0.00
Biogen (BIIB) United States $21.478B 9.22
Illumina (ILMN) United States $21.252B 77.46
BeiGene (BGNE) Cayman Islands $17.031B 0.00
Moderna (MRNA) United States $15.223B 0.00
Genmab (GMAB) Denmark $13.295B 19.50
Incyte (INCY) United States $12.919B 0.00
Insmed (INSM) United States $12.418B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.388B 28.76
Sarepta Therapeutics (SRPT) United States $11.412B 102.99
Bio-Techne Corp (TECH) United States $11.343B 43.80
Vaxcyte (PCVX) United States $10.745B 0.00
Exact Sciences (EXAS) United States $10.385B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.189B 42.09
QIAGEN (QGEN) Netherlands $10.114B 20.81
Exelixis (EXEL) United States $9.618B 21.87
Bio-Rad Laboratories (BIO.B) United States $9.123B 31.00
Intra-Cellular Therapies (ITCI) United States $8.920B 0.00
Roivant Sciences (ROIV) United Kingdom $8.371B 0.00
Ascendis Pharma (ASND) Denmark $8.353B 0.00
Repligen (RGEN) United States $8.210B 106.96
Jazz Pharmaceuticals (JAZZ) Ireland $7.427B 7.26
Revolution Medicines (RVMD) United States $7.282B 0.00
Legend Biotech (LEGN) United States $6.213B 0.00
Halozyme Therapeutics (HALO) United States $6.020B 13.60
Nuvalent (NUVL) United States $6.014B 0.00
Blueprint Medicines (BPMC) United States $5.649B 0.00
Cytokinetics (CYTK) United States $5.516B 0.00
Telix Pharmaceuticals (TLX) Australia $5.469B 0.00
Alkermes (ALKS) Ireland $4.849B 16.29
TG Therapeutics (TGTX) United States $4.818B 0.00
Krystal Biotech (KRYS) United States $4.626B 76.59
Viking Therapeutics (VKTX) United States $4.624B 0.00
Axsome Therapeutics (AXSM) United States $4.349B 0.00
ADMA Biologics Inc (ADMA) United States $4.231B 44.75
Apellis Pharmaceuticals (APLS) United States $4.122B 0.00
Arcellx (ACLX) United States $4.067B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.014B 0.00
Scholar Rock Holding (SRRK) United States $3.940B 0.00
Guardant Health (GH) United States $3.846B 0.00
Immunovant (IMVT) United States $3.766B 0.00
Avidity Biosciences (RNA) United States $3.705B 0.00
Alvotech (ALVO) Luxembourg $3.651B 0.00
Biohaven (BHVN) United States $3.574B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.447B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.410B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.349B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.315B 0.00
NovoCure (NVCR) Jersey $3.289B 0.00
Denali Therapeutics (DNLI) United States $3.093B 0.00
Janux Therapeutics (JANX) United States $2.978B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.966B 0.00
Edgewise Therapeutics (EWTX) United States $2.916B 0.00
Amicus Therapeutics (FOLD) United States $2.907B 0.00
Merus (MRUS) Netherlands $2.882B 0.00
Zai Lab (ZLAB) China $2.848B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.784B 21.45
Vericel (VCEL) United States $2.712B 915.83
Vera Therapeutics (VERA) United States $2.663B 0.00
Twist Bioscience (TWST) United States $2.589B 0.00
SpringWorks Therapeutics (SWTX) United States $2.587B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.547B 0.00
Kymera Therapeutics (KYMR) United States $2.535B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.426B 0.00
Protagonist Therapeutics (PTGX) United States $2.357B 14.86
Beam Therapeutics (BEAM) United States $2.223B 0.00
Geron (GERN) United States $2.212B 0.00
Iovance Biotherapeutics (IOVA) United States $2.201B 0.00
Ligand Pharmaceuticals (LGND) United States $2.153B 53.75
IDEAYA Biosciences (IDYA) United States $2.143B 0.00
CG Oncology (CGON) United States $2.131B 0.00
Apogee Therapeutics (APGE) United States $2.117B 0.00
NeoGenomics (NEO) United States $2.105B 0.00
Bavarian Nordic (BVNRY) Denmark $2.091B 12.81
Agios Pharmaceuticals (AGIO) United States $2.042B 0.00
WAVE Life Sciences (WVE) Singapore $2.012B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.988B 0.00
Akero Therapeutics (AKRO) United States $1.982B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.974B 0.00
Belite Bio (BLTE) United States $1.942B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.933B 16.06
Mesoblast (MESO) Australia $1.914B 0.00
Disc Medicine (IRON) United States $1.873B 0.00
ImmunityBio (IBRX) United States $1.861B 0.00
Galapagos (GLPG) Belgium $1.738B 0.00
MannKind (MNKD) United States $1.737B 45.00
Structure Therapeutics (GPCR) United States $1.716B 0.00
Certara (CERT) United States $1.698B 47.96
Neumora Therapeutics (NMRA) United States $1.696B 0.00
Celldex Therapeutics (CLDX) United States $1.684B 0.00
Dynavax Technologies (DVAX) United States $1.677B 98.15
Fortrea Holdings (FTRE) United States $1.659B 52.86
Arcutis Biotherapeutics (ARQT) United States $1.652B 0.00
Viridian Therapeutics (VRDN) United States $1.484B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.479B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.422B 0.00
Nurix Therapeutics (NRIX) United States $1.420B 0.00
Arcus Biosciences (RCUS) United States $1.415B 0.00
Novavax (NVAX) United States $1.390B 0.00
Travere Therapeutics (TVTX) United States $1.358B 0.00
Praxis Precision Medicines (PRAX) United States $1.358B 0.00
MiMedx (MDXG) United States $1.334B 34.92
Day One Biopharmaceuticals (DAWN) United States $1.257B 0.00
Intellia Therapeutics (NTLA) United States $1.230B 0.00
Arvinas (ARVN) United States $1.225B 0.00
Myriad Genetics (MYGN) United States $1.199B 0.00
Spyre Therapeutics (SYRE) United States $1.190B 0.00
ANI Pharmaceuticals (ANIP) United States $1.141B 15.55
Syndax Pharmaceuticals (SNDX) United States $1.097B 0.00
Septerna (SEPN) United States $1.039B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.036B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.035B 0.00
Vir Biotechnology (VIR) United States $1.015B 0.00
Gyre Therapeutics (GYRE) United States $0.997B 0.00
Zymeworks (ZYME) United States $0.935B 0.00
Poseida Therapeutics (PSTX) United States $0.920B 0.00
Nuvation Bio (NUVB) United States $0.905B 0.00
Pacira BioSciences (PCRX) United States $0.904B 8.51
Bicara Therapeutics (BCAX) United States $0.903B 0.00
Liquidia Technologies (LQDA) United States $0.896B 0.00
Upstream Bio (UPB) United States $0.890B 0.00
Adaptive Biotechnologies (ADPT) United States $0.885B 0.00
ArriVent BioPharma (AVBP) United States $0.864B 0.00
Cogent Biosciences (COGT) United States $0.862B 0.00
Prothena (PRTA) Ireland $0.861B 0.00
LENZ Therapeutics (LENZ) United States $0.833B 0.00
Replimune (REPL) United States $0.822B 0.00
Immatics (IMTX) Germany $0.821B 0.00
Pliant Therapeutics (PLRX) United States $0.809B 0.00
AbCellera Biologics (ABCL) Canada $0.800B 0.00
Cytek Biosciences (CTKB) United States $0.797B 0.00
Avid Bioservices (CDMO) United States $0.789B 0.00
Castle Biosciences (CSTL) United States $0.759B 135.45
UniQure (QURE) Netherlands $0.754B 0.00
89BIO (ETNB) United States $0.746B 0.00
Tyra Biosciences (TYRA) United States $0.734B 0.00
Anavex Life Sciences (AVXL) United States $0.718B 0.00
Kura Oncology (KURA) United States $0.698B 0.00
Erasca (ERAS) United States $0.693B 0.00
Immunome (IMNM) United States $0.692B 0.00
Oculis Holding AG (OCS) Switzerland $0.689B 0.00
Keros Therapeutics (KROS) United States $0.685B 0.00
Dianthus Therapeutics (DNTH) United States $0.682B 0.00
MBX Biosciences (MBX) United States $0.677B 0.00
CureVac (CVAC) Germany $0.669B 5.44
Rapport Therapeutics (RAPP) United States $0.653B 0.00
Tectonic Therapeutic (TECX) United States $0.650B 0.00
Entrada Therapeutics (TRDA) United States $0.647B 10.87
Sinovac Biotech (SVA) China $0.645B 0.00
Cullinan Therapeutics (CGEM) United States $0.638B 0.00
CARGO Therapeutics (CRGX) United States $0.622B 0.00
Arbutus Biopharma (ABUS) United States $0.608B 0.00
Pharming Group (PHAR) Netherlands $0.606B 0.00
Stoke Therapeutics (STOK) United States $0.599B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.596B 0.00
Mineralys Therapeutics (MLYS) United States $0.589B 0.00
GRAIL (GRAL) United States $0.576B 0.00
Annexon (ANNX) United States $0.556B 0.00
Oric Pharmaceuticals (ORIC) United States $0.543B 0.00
CorMedix Inc (CRMD) United States $0.538B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.535B 0.00
Astria Therapeutics (ATXS) United States $0.533B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.514B 0.00
Terns Pharmaceuticals (TERN) United States $0.514B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.510B 0.00
PureTech Health (PRTC) United States $0.505B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.502B 0.00
Abivax SA (ABVX) France $0.492B 0.00
Third Harmonic Bio (THRD) United States $0.490B 0.00
Cartesian Therapeutics (RNAC) United States $0.490B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.486B 0.00
Sangamo Therapeutics (SGMO) United States $0.482B 0.00
Kodiak Sciences (KOD) United States $0.457B 0.00
AnaptysBio (ANAB) United States $0.456B 0.00
MeiraGTx Holdings (MGTX) United States $0.456B 0.00
Celcuity (CELC) United States $0.446B 0.00
MaxCyte (MXCT) United States $0.438B 0.00
Emergent Biosolutions (EBS) United States $0.437B 0.00
Humacyte (HUMA) United States $0.435B 0.00
IGM Biosciences (IGMS) United States $0.419B 0.00
Codexis (CDXS) United States $0.417B 0.00
ChromaDex (CDXC) United States $0.413B 541.00
Zenas BioPharma (ZBIO) United States $0.408B 0.00
Alumis (ALMS) United States $0.408B 0.00
Aura Biosciences (AURA) United States $0.405B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.402B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.400B 0.00
Alpha Teknova (TKNO) United States $0.386B 0.00
Allogene Therapeutics (ALLO) United States $0.386B 0.00
GH Research (GHRS) Ireland $0.384B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.384B 0.00
REGENXBIO (RGNX) United States $0.367B 0.00
Prime Medicine (PRME) United States $0.366B 0.00
Sana Biotechnology (SANA) United States $0.357B 0.00
Contineum Therapeutics (CTNM) United States $0.344B 0.00
Northwest Biotherapeutics (NWBO) United States $0.341B 0.00
Design Therapeutics (DSGN) United States $0.339B 0.00
Kamada (KMDA) Israel $0.336B 20.89
Absci (ABSI) United States $0.335B 0.00
Olema Pharmaceuticals (OLMA) United States $0.332B 0.00
Neurogene (NGNE) United States $0.328B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.327B 0.00
Candel Therapeutics (CADL) United States $0.323B 0.00
ACELYRIN, INC (SLRN) United States $0.323B 0.00
Jasper Therapeutics (JSPR) United States $0.323B 0.00
Revance Therapeutics (RVNC) United States $0.320B 0.00
Eton Pharmaceuticals (ETON) United States $0.320B 0.00
Trevi Therapeutics (TRVI) United States $0.319B 0.00
Tango Therapeutics (TNGX) United States $0.316B 0.00
Voyager Therapeutics (VYGR) United States $0.311B 8.01
Prima BioMed (IMMP) Australia $0.308B 0.00
Sage Therapeutics (SAGE) United States $0.306B 0.00
XOMA Royalty (XOMA) United States $0.296B 0.00
Benitec Biopharma (BNTC) United States $0.283B 0.00
Foghorn Therapeutics (FHTX) United States $0.277B 0.00
C4 Therapeutics (CCCC) United States $0.271B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.270B 0.00
AC Immune (ACIU) Switzerland $0.267B 0.00
ATyr Pharma (ATYR) United States $0.264B 0.00
Atea Pharmaceuticals (AVIR) United States $0.264B 0.00
ITeos Therapeutics (ITOS) United States $0.264B 0.00
EnGene Holdings (ENGN) Canada $0.264B 0.00
Lifecore Biomedical (LFCR) United States $0.260B 0.00
BioStem Technologies (BSEM) $0.256B 22.68
Chimerix (CMRX) United States $0.256B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.252B 0.00
Urogen Pharma (URGN) United States $0.251B 0.00
Renovaro (RENB) United States $0.245B 0.00
Rezolute (RZLT) United States $0.245B 0.00
Abeona Therapeutics (ABEO) United States $0.245B 0.00
Artiva Biotherapeutics (ARTV) United States $0.243B 0.00
Anika Therapeutics (ANIK) United States $0.239B 0.00
Cardiff Oncology (CRDF) United States $0.230B 0.00
Nautilus Biotechnology (NAUT) United States $0.226B 0.00
Ocugen (OCGN) United States $0.224B 0.00
Fulcrum Therapeutics (FULC) United States $0.217B 0.00
Mersana Therapeutics (MRSN) United States $0.215B 0.00
Precigen (PGEN) United States $0.213B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.212B 0.00
Molecular Partners AG (MOLN) Switzerland $0.211B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.209B 0.00
DiaMedica Therapeutics (DMAC) United States $0.208B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.205B 0.00
Inhibrx Biosciences (INBX) United States $0.201B 0.00
Verastem (VSTM) United States $0.198B 0.00
XBiotech (XBIT) United States $0.193B 0.00
Amarin (AMRN) Ireland $0.191B 0.00
Gossamer Bio (GOSS) United States $0.191B 0.00
Fate Therapeutics (FATE) United States $0.189B 0.00
Opthea (OPT) Australia $0.189B 0.00
Compass Therapeutics (CMPX) United States $0.189B 0.00
GENFIT S.A (GNFT) France $0.186B 0.00
BioAge Labs (BIOA) United States $0.185B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.182B 0.00
Inozyme Pharma (INZY) United States $0.181B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.178B 0.00
Innate Pharma S.A (IPHA) France $0.175B 0.00
Alector (ALEC) United States $0.174B 0.00
Bright Minds Biosciences (DRUG) United States $0.173B 0.00
Coherus BioSciences (CHRS) United States $0.171B 0.00
TuHURA Biosciences (HURA) United States $0.169B 0.00
Semper Paratus Acquisition (TVGN) United States $0.169B 0.00
Kyverna Therapeutics (KYTX) United States $0.167B 0.00
ScPharmaceuticals (SCPH) United States $0.166B 0.00
Checkpoint Therapeutics (CKPT) United States $0.165B 0.00
Greenwich LifeSciences (GLSI) United States $0.165B 0.00
Caribou Biosciences (CRBU) United States $0.164B 0.00
Ventyx Biosciences (VTYX) United States $0.161B 0.00
Adherex Technologies (FENC) United States $0.160B 0.00
Solid Biosciences (SLDB) United States $0.160B 0.00
Cidara Therapeutics (CDTX) United States $0.159B 0.00
Seres Therapeutics (MCRB) United States $0.157B 0.00
TScan Therapeutics (TCRX) United States $0.156B 0.00
Sagimet Biosciences (SGMT) United States $0.156B 0.00
Nkarta (NKTX) United States $0.155B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.154B 0.00
Zura Bio (ZURA) United States $0.153B 0.00
2seventy Bio (TSVT) United States $0.151B 0.00
Sutro Biopharma (STRO) United States $0.150B 0.00
Biomea Fusion (BMEA) United States $0.148B 0.00
Actuate Therapeutics (ACTU) United States $0.138B 0.00
Aligos Therapeutics (ALGS) United States $0.138B 0.00
Seer (SEER) United States $0.137B 0.00
Puma Biotechnology (PBYI) United States $0.136B 5.79
Compugen (CGEN) Israel $0.136B 76.00
PepGen (PEPG) United States $0.133B 0.00
Climb Bio (CLYM) United States $0.131B 0.00
Instil Bio (TIL) United States $0.131B 0.00
Akoya Biosciences (AKYA) United States $0.126B 0.00
Monopar Therapeutics (MNPR) United States $0.126B 0.00
InflaRx (IFRX) Germany $0.125B 0.00
Inventiva S.A (IVA) France $0.124B 0.00
Black Diamond Therapeutics (BDTX) United States $0.124B 0.00
Elutia (ELUT) United States $0.122B 0.00
Applied Therapeutics (APLT) United States $0.119B 0.00
Invizyne Technologies (IZTC) United States $0.118B 0.00
Allakos (ALLK) United States $0.115B 0.00
Cabaletta Bio (CABA) United States $0.113B 0.00
Tenaya Therapeutics (TNYA) United States $0.112B 0.00
Editas Medicine (EDIT) United States $0.111B 0.00
TELA Bio (TELA) United States $0.110B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.108B 0.00
CAMP4 Therapeutics (CAMP) United States $0.108B 0.00
Leap Therapeutics (LPTX) United States $0.107B 0.00
MediciNova (MNOV) United States $0.106B 0.00
X4 Pharmaceuticals (XFOR) United States $0.104B 0.00
BioHarvest Sciences (BHST) Canada $0.102B 0.00
Alto Neuroscience (ANRO) United States $0.100B 0.00
Genenta Science S.p.A (GNTA) Italy $0.098B 0.00
INmune Bio (INMB) United States $0.098B 0.00
Adverum Biotechnologies (ADVM) United States $0.098B 0.00
Immunic (IMUX) United States $0.094B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.091B 0.00
HilleVax (HLVX) United States $0.091B 0.00
Nuvectis Pharma (NVCT) United States $0.091B 0.00
Bluebird Bio (BLUE) United States $0.090B 0.00
Adagene (ADAG) China $0.089B 0.00
Cellectis S.A (CLLS) France $0.088B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.088B 0.00
Skye Bioscience (SKYE) United States $0.087B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.087B 0.00
Coya Therapeutics (COYA) United States $0.086B 0.00
CytomX Therapeutics (CTMX) United States $0.086B 6.47
Scilex Holding (SCLX) United States $0.084B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.082B 0.00
23andMe Holding (ME) United States $0.080B 0.00
Adlai Nortye (ANL) Cayman Islands $0.079B 0.00
ALX Oncology Holdings (ALXO) United States $0.078B 0.00
Ikena Oncology (IKNA) United States $0.078B 0.00
I-Mab (IMAB) China $0.078B 0.00
Alpha Cognition (ACOG) Canada $0.078B 0.00
Quince Therapeutics (QNCX) United States $0.077B 0.00
Entera Bio (ENTX) Israel $0.077B 0.00
Abpro Holdings (ABP) United States $0.077B 0.00
Theratechnologies (THTX) Canada $0.076B 0.00
Genelux (GNLX) United States $0.076B 0.00
Rani Therapeutics Holdings (RANI) United States $0.074B 0.00
Aerovate Therapeutics (AVTE) United States $0.073B 0.00
Ovid Therapeutics (OVID) United States $0.072B 0.00
Generation Bio (GBIO) United States $0.072B 0.00
Adicet Bio (ACET) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
FibroBiologics (FBLG) United States $0.070B 0.00
Werewolf Therapeutics (HOWL) United States $0.070B 0.00
Oncolytics Biotech (ONCY) Canada $0.068B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.068B 0.00
Vigil Neuroscience (VIGL) United States $0.068B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
PDS Biotechnology (PDSB) United States $0.065B 0.00
Agenus (AGEN) United States $0.065B 0.00
Cue Biopharma (CUE) United States $0.065B 0.00
Galena Biopharma (SLS) United States $0.063B 0.00
DBV Technologies S.A (DBVT) France $0.063B 0.00
VistaGen Therapeutics (VTGN) United States $0.063B 0.00
BGM Group (BGM) China $0.061B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
Vor Biopharma (VOR) $0.061B 0.00
Annovis Bio (ANVS) United States $0.061B 0.00
BeyondSpring (BYSI) United States $0.060B 0.00
BioAtla (BCAB) United States $0.058B 0.00
Atara Biotherapeutics (ATRA) United States $0.057B 0.00
Aadi Bioscience (AADI) United States $0.057B 0.00
Immuneering (IMRX) United States $0.057B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.057B 0.00
Dyadic (DYAI) United States $0.056B 0.00
Boundless Bio (BOLD) United States $0.056B 0.00
Repare Therapeutics (RPTX) Canada $0.056B 0.00
Kronos Bio (KRON) United States $0.056B 0.00
Connect Biopharma Holdings (CNTB) United States $0.055B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Spero Therapeutics (SPRO) United States $0.054B 14.26
Invivyd (IVVD) United States $0.051B 0.00
IO Biotech (IOBT) Denmark $0.050B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.050B 0.00
Shattuck Labs (STTK) United States $0.050B 0.00
Celularity (CELU) United States $0.049B 0.00
Inovio Pharmaceuticals (INO) United States $0.048B 0.00
Fortress Biotech (FBIO) United States $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.046B 0.00
Omega Therapeutics (OMGA) United States $0.045B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.042B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.041B 0.00
Xilio Therapeutics (XLO) United States $0.041B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.041B 0.00
Exicure (XCUR) United States $0.041B 0.00
Q32 Bio (QTTB) United States $0.041B 0.00
Rallybio (RLYB) United States $0.041B 0.00
Passage Bio (PASG) United States $0.040B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.040B 0.00
Estrella Immunopharma (ESLA) United States $0.040B 0.00
Lexaria Bioscience (LEXX) Canada $0.039B 0.00
Aileron Therapeutics (ALRN) United States $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.038B 0.00
CalciMedica (CALC) United States $0.037B 0.00
Enzo Biochem (ENZ) United States $0.037B 0.00
Elevation Oncology (ELEV) United States $0.037B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
SAB Biotherapeutics (SABS) United States $0.036B 0.00
Clene (CLNN) United States $0.036B 0.00
Precision BioSciences (DTIL) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
Oncobiologics (OTLK) United States $0.033B 0.00
Opus Genetics (IRD) United States $0.031B 0.00
Intensity Therapeutics (INTS) United States $0.030B 0.00
Beyond Air (XAIR) United States $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.029B 0.00
Rapt Therapeutics (RAPT) United States $0.028B 0.00
KALA BIO (KALA) United States $0.028B 0.00
RenovoRx (RNXT) United States $0.028B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
OnKure Therapeutics (OKUR) United States $0.027B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.027B 0.00
NextCure (NXTC) United States $0.027B 0.00
Medicus Pharma (MDCX) Canada $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.026B 0.00
Cognition Therapeutics (CGTX) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
BRIACELL THERAP (BCTX) Canada $0.026B 0.00
HOOKIPA Pharma (HOOK) United States $0.026B 0.00
Gelteq (GELS) Australia $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
LakeShore Biopharma (LSB) China $0.025B 0.00
Pluri (PLUR) Israel $0.024B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Longeveron (LGVN) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Cara Therapeutics (CARA) United States $0.022B 0.00
GeoVax Labs (GOVX) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Cocrystal Pharma (COCP) United States $0.021B 0.00
Equillium (EQ) United States $0.021B 0.00
Athira Pharma (ATHA) United States $0.021B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
Ocean Biomedical (OCEA) United States $0.021B 0.00
Bionano Genomics (BNGO) United States $0.020B 0.00
NKGen Biotech (NKGN) United States $0.020B 0.00
MiNK Therapeutics (INKT) United States $0.020B 0.00
Bolt Biotherapeutics (BOLT) United States $0.019B 0.00
Affimed (AFMD) Germany $0.019B 0.00
Tenax Therapeutics (TENX) United States $0.019B 0.00
BioAffinity Technologies (BIAF) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.018B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
Aprea Therapeutics (APRE) United States $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
IN8bio (INAB) United States $0.017B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.017B 0.00
UNITY Biotechnology (UBX) United States $0.016B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Spruce Biosciences (SPRB) United States $0.016B 0.00
HCW Biologics (HCWB) United States $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
CervoMed (CRVO) United States $0.014B 0.00
BioXcel Therapeutics (BTAI) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Cingulate (CING) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
Aptose Biosciences (APTO) Canada $0.010B 0.00
Apollomics (APLM) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Polyrizon (PLRZ) Israel $0.010B 0.00
Mainz Biomed (MYNZ) Germany $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.008B 0.00
BioCardia (BCDA) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Vincerx Pharma (VINC) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Galecto (GLTO) Denmark $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.006B 0.00
Moleculin Biotech (MBRX) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Evaxion Biotech (EVAX) Denmark $0.005B 0.00
Carmell (CTCX) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Bionomics (BNOX) Australia $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
AquaBounty Technologies (AQB) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Eterna Therapeutics (ERNA) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00